Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: study protocol for a randomized pilot trial. - Wei Wu; Heran Deng; Nanyan Rao; Na You; Yaping Yang; Minghui Cao; Jieqiong Liu; Wu, Wei; Deng, Heran; Rao, Nanyan; You, Na; Yang, Yaping; et al. (Trials, 2017)